NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) Net Long-Term Debt Issued (Repaid) (2020)

Updated

NovaBridge Biosciences' Net Long-Term Debt Issued (Repaid) was $9.85 million in FY2023, up 258.4% from $2.75 million in FY2022.

Analysis

NovaBridge Biosciences (NBP) Net Long-Term Debt Issued (Repaid) (2020) Analysis & Trends

From FY2017 onward, NovaBridge Biosciences has reported Net Long-Term Debt Issued (Repaid) for 6 years.

  • Net Long-Term Debt Issued (Repaid) shows a five-year compound annual growth rate of 9.8% (FY2018 to FY2023).
  • The FY2023 figure marks the highest annual Net Long-Term Debt Issued (Repaid) since FY2017.
  • Per Business Quant data, Net Long-Term Debt Issued (Repaid) in earlier years was $2.75 million in FY2022, -$7.66 million in FY2020 and -$4.31 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -14.45 Mn
API Access

NovaBridge Biosciences Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=NBP&period=max&api_key=YOUR_API_KEY